These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7795238)

  • 1. p16INK4A and p15INK4B gene deletions in primary leukemias.
    Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
    Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
    Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
    Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
    Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
    Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues.
    Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Hayakawa T
    Cancer Lett; 1995 Nov; 97(2):241-7. PubMed ID: 7497469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
    Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
    Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.
    Hebert J; Cayuela JM; Berkeley J; Sigaux F
    Blood; 1994 Dec; 84(12):4038-44. PubMed ID: 7994022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
    Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
    Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
    Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
    Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
    Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
    Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer.
    Güran S; Pak I
    Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.